Format

Send to

Choose Destination
Adv Exp Med Biol. 2017;982:577-594. doi: 10.1007/978-3-319-55330-6_30.

Mitochondrial Heteroplasmy.

Author information

1
International Scientific Information, Inc., 150 Broadhollow Rd, Ste 114, Melville, NY, 11747, USA. george.stefano@mitogenetics.com.
2
Cardiometabolic Designs LLC, 160 W15th Ave, Suite 303, Sea Cliff, NY, 11579, USA.
3
Division of Neuroscience, Bonoi Academy of Science & Education, Chapel Hill, NC, 27510, USA.
4
Department of Anesthesiology, Affiliated Hospital of OB/GYN, Nanjing Medical University, Nanjing, 210004, China.
5
International Scientific Information, Inc., 150 Broadhollow Rd, Ste 114, Melville, NY, 11747, USA.

Abstract

Genetic polymorphisms, in concert with well-characterized etiology and progression of major pathologies, plays a significant role in aberrant processes afflicting human populations. Mitochondrial heteroplasmy represents a dynamically determined co-expression of inherited polymorphisms and somatic pathology in varying ratios within individual mitochondrial DNA (mtDNA) genomes with repetitive patterns of tissue specificity. The ratios of the MtDNA genomes represent a balance between healthy and pathological cellular outcomes. Mechanistically, cardiomyopathies have profound alterations of normative mitochondrial function. Certain allele imbalances in the nuclear mitochondrial genome are associated with key energy mitochondrial proteins. Mitochondrial heteroplasmy may manifest itself at critical protein expression points, e.g., cytochrome c oxidase (COX). Pathological mtDNA mutations also are associated with the development of congestive heart failure. Interestingly, mitochondrial 'normal vs. abnormal' ratios of various heteroplasmic populations may occur in families. In the translational context of human health and disease, we discuss the need for determining critical foci to probe multiple biological roles of mitochondrial heteroplasmy in cardiomyopathy.

KEYWORDS:

Bioenergetics; Heart; Mitochondria; Mitochondrial DNA/mtDNA; Myocardium; Myocytes; Myopathy; Translational; mtDNA heteroplasmy

PMID:
28551808
DOI:
10.1007/978-3-319-55330-6_30
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center